FIELD: medicine. SUBSTANCE: invention relates to the use of heterylthioacetic acid alkanolammonium salts as new antiinflammatory agents, in part, tris-(2-hydroxyethyl)-ammonium indolyl-3-thioacetate. Agent shows high antiinflammatory activity at acute aseptic inflammation and can be used in medicinal therapy at traumatic tissue damages, myocardial infarction and postoperative period. EFFECT: enhanced effectiveness of agent. 5 dwg
Title | Year | Author | Number |
---|---|---|---|
HYPOCHOLESTEROLEMIC AGENT | 1992 |
|
RU2034540C1 |
METHOD OF TREATMENT OF WOMEN WITH ACNE DISEASE | 1998 |
|
RU2148994C1 |
METHOD OF PREPARING THE TOTAL FLAVONOIDS SHOWING ANTIINFLAMMATORY AND SPASMOLYTIC EFFECT | 1993 |
|
RU2095075C1 |
METHOD FOR PREDICTING DESTRUCTIVE ERYSIPELAS FORM DEVELOPMENT | 2000 |
|
RU2191379C2 |
METHOD OF TREATING CHRONIC PURULENT RHINOSINUSITES | 2000 |
|
RU2161983C1 |
REMEDY SHOWING ANTIMICROBIAL AND ANTI-INFLAMMATION ACTIVITY | 1996 |
|
RU2182829C2 |
PROTECTIVE AGENT AGAINST CARDIOGENIC SHOCK AND STRESS | 1992 |
|
RU2080861C1 |
METHOD TO TREAT CHRONIC PURULENT RHINOSINUSITIS | 2001 |
|
RU2178676C1 |
N,N-DIBENZYLGLYCINE AND ITS DERIVATIVES SHOWING CAPABILITY TO PENETRATE THROUGH THE BLOOD-BRAIN BARRIER | 1992 |
|
RU2086238C1 |
METHOD FOR LIMITED CHRONIC PLEURAL EMPYEMA SIMULATION | 2016 |
|
RU2636177C1 |
Authors
Dates
1997-08-10—Published
1992-08-06—Filed